株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

陰圧創傷治療 (NPWT) :パイプライン製品の分析

Negative Pressure Wound Therapy (NPWT) - Medical Devices Pipeline Assessment, 2017

発行 GlobalData 商品コード 333943
出版日 ページ情報 英文 96 Pages
即納可能
価格
本日の銀行送金レート: 1USD=113.77円で換算しております。
Back to Top
陰圧創傷治療 (NPWT) :パイプライン製品の分析 Negative Pressure Wound Therapy (NPWT) - Medical Devices Pipeline Assessment, 2017
出版日: 2017年04月10日 ページ情報: 英文 96 Pages
概要

当レポートでは、現在開発中の陰圧創傷治療 (NPWT) のパイプライン製品情報について調査分析し、主要製品・プロジェクト、主要企業、治験情報、最近の動向などについて、体系的な情報を提供しています。

第1章 目次

第2章 イントロダクション

  • 陰圧創傷治療 (NPWT) の概要

第3章 開発中の製品

  • NPWT - パイプライン製品:開発段階別
  • NPWT - パイプライン製品:地域別
  • NPWT - パイプライン製品:規制経路別
  • NPWT - パイプライン製品:承認時期別 (予定)

第4章 陰圧創傷治療 (NPWT) :開発中のパイプライン製品 (企業別)

  • NPWT企業 - パイプライン製品:開発段階別
  • NPWT - パイプライン製品:開発段階別

第5章 陰圧創傷治療 (NPWT) 企業と製品の概要

第6章 陰圧創傷治療 (NPWT) :最近の動向

第7章 付録

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDME0328EPD

GlobalData's Medical Devices sector report, "Negative Pressure Wound Therapy (NPWT) - Medical Devices Pipeline Assessment, 2017" provides an overview of Negative Pressure Wound Therapy (NPWT) currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Negative Pressure Wound Therapy (NPWT) pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Negative Pressure Wound Therapy (NPWT) under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Negative Pressure Wound Therapy (NPWT) and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Negative Pressure Wound Therapy (NPWT) under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 5
  • 1.2 List of Figures 5

2 Introduction 7

  • 2.1 Negative Pressure Wound Therapy (NPWT) Overview 7

3 Products under Development 8

  • 3.1 Negative Pressure Wound Therapy (NPWT) - Pipeline Products by Stage of Development 8
  • 3.2 Negative Pressure Wound Therapy (NPWT) - Pipeline Products by Territory 9
  • 3.3 Negative Pressure Wound Therapy (NPWT) - Pipeline Products by Regulatory Path 10
  • 3.4 Negative Pressure Wound Therapy (NPWT) - Pipeline Products by Estimated Approval Date 11

4 Negative Pressure Wound Therapy (NPWT) - Pipeline Products under Development by Companies 12

  • 4.1 Negative Pressure Wound Therapy (NPWT) Companies - Pipeline Products by Stage of Development 12
  • 4.2 Negative Pressure Wound Therapy (NPWT) - Pipeline Products by Stage of Development 13

5 Negative Pressure Wound Therapy (NPWT) Companies and Product Overview 14

  • 5.1 Acelity L.P. Inc. Company Overview 14
    • 5.1.1 Acelity L.P. Inc. Pipeline Products & Ongoing Clinical Trials Overview 14
  • 5.2 Adept Medical Ltd Company Overview 16
    • 5.2.1 Adept Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 16
  • 5.3 Applied Tissue Technologies LLC Company Overview 17
    • 5.3.1 Applied Tissue Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 17
  • 5.4 Invacare Corporation Company Overview 18
    • 5.4.1 Invacare Corporation Pipeline Products & Ongoing Clinical Trials Overview 18
  • 5.5 LifeMedix, LLC Company Overview 19
    • 5.5.1 LifeMedix, LLC Pipeline Products & Ongoing Clinical Trials Overview 19
  • 5.6 Montana State University Company Overview 20
    • 5.6.1 Montana State University Pipeline Products & Ongoing Clinical Trials Overview 20
  • 5.7 Otivio AS Company Overview 21
    • 5.7.1 Otivio AS Pipeline Products & Ongoing Clinical Trials Overview 21
  • 5.8 Shieldheart Medtech AB Company Overview 22
    • 5.8.1 Shieldheart Medtech AB Pipeline Products & Ongoing Clinical Trials Overview 22
  • 5.9 Smith & Nephew Plc Company Overview 23
    • 5.9.1 Smith & Nephew Plc Pipeline Products & Ongoing Clinical Trials Overview 23
  • 5.10 University of Pisa Company Overview 25
    • 5.10.1 University of Pisa Pipeline Products & Ongoing Clinical Trials Overview 25
  • 5.11 Wake Forest Baptist Medical Center Company Overview 26
    • 5.11.1 Wake Forest Baptist Medical Center Pipeline Products & Ongoing Clinical Trials Overview 26
  • 5.12 Worldwide Innovative Healthcare, Inc. Company Overview 27
    • 5.12.1 Worldwide Innovative Healthcare, Inc. Pipeline Products & Ongoing Clinical Trials Overview 27

6 Negative Pressure Wound Therapy (NPWT)- Recent Developments 28

  • 6.1 Mar 31, 2017: Acelity Introduces V.A.C. VERAFLO CLEANSE CHOICE Dressing 28
  • 6.2 Mar 23, 2017: NanoVibronix Raises USD0.1 Million in Venture Financing 29
  • 6.3 Mar 09, 2017: US Patent and Trademark Office Grants Patent to NanoVibronix for Surface Acoustic Wave Technology 29
  • 6.4 Feb 10, 2017: IASIS Healthcare Announces First Quarter 2017 Results 29
  • 6.5 Feb 09, 2017: Smith & Nephew Fourth Quarter Trading and Full Year 2016 Results 30
  • 6.6 Feb 09, 2017: Smith & Nephew: Directorate Change 36
  • 6.7 Feb 09, 2017: Invacare Announces Financial Results for the Fourth Quarter and Full Year Ended December 31, 2016 36
  • 6.8 Feb 09, 2017: Sonoma Pharmaceuticals Reports Financial Results for Fiscal Third Quarter 2017 42
  • 6.9 Feb 07, 2017: Cardinal Health Reports Second-quarter Results for Fiscal Year 2017 43
  • 6.10 Jan 31, 2017: Sonoma Pharmaceuticals Appoints Marc Umscheid As Chief Strategy And Marketing Officer 45
  • 6.11 Jan 31, 2017: Invacare Announces Reduction in Force as Part of Its Ongoing Transformation 45
  • 6.12 Jan 25, 2017: Shore Capital Partners Invests in Argentum Medical and Cura Surgical 46
  • 6.13 Jan 12, 2017: Confirmation of CFO leaving Smith & Nephew 46
  • 6.14 Jan 09, 2017: Cardinal Health Reaches Settlement With West Virginia 46
  • 6.15 Dec 23, 2016: Cardinal Health Announces Civil Settlement with DOJ 47
  • 6.16 Dec 21, 2016: Smith & Nephew wins prestigious Galien Award for PICO Negative Pressure Wound Therapy innovation 47
  • 6.17 Dec 20, 2016: IASIS Healthcare Announces Fourth Quarter and Year-End 2016 Results 48
  • 6.18 Dec 05, 2016: Oculus Innovative changes name to Sonoma Pharmaceuticals 50
  • 6.19 Nov 30, 2016: Graham Baker appointed Chief Financial Officer 51
  • 6.20 Nov 28, 2016: Invacare Appoints Susan Alexander to Board of Directors 51
  • 6.21 Nov 22, 2016: New WHO guidelines recommend the use of NPWT to help reduce the risk of Surgical Site Infection 52
  • 6.22 Nov 15, 2016: NanoVibronix Provides Third Quarter 2016 Business Update 52
  • 6.23 Nov 10, 2016: Oculus Innovative Sciences Reports Financial Results for Fiscal Second Quarter 2017 53
  • 6.24 Nov 04, 2016: World Health Organization Issues New Guidelines Suggesting Use of Prophylactic Negative Pressure Wound Therapy to Reduce the Risk of Surgical Site Infections (SSIs) 55
  • 6.25 Nov 04, 2016: World Health Organization Issues New Guidelines Suggesting Use of Prophylactic Negative Pressure Wound Therapy to Reduce the Risk of Surgical Site Infections 56
  • 6.26 Nov 03, 2016: Smith & Nephew Third Quarter 2016 Trading Report 57
  • 6.27 Oct 31, 2016: Cardinal Health Reports First-quarter Results for Fiscal Year 2017 58
  • 6.28 Oct 31, 2016: Invacare Announces Financial Results for the Third Quarter and First Nine Months of 2016 59
  • 6.29 Oct 26, 2016: Acelity Embarks Upon the Next Frontier in Advanced Wound Therapy with the Launch of a Telehealth Solution for the Home Care Setting 65
  • 6.30 Oct 25, 2016: Invacare Announces New General Manager for Europe Segment 66
  • 6.31 Oct 20, 2016: NanoVibronix Expands Senior Management Team and Board of Directors 66
  • 6.32 Sep 26, 2016: Jon Giacomin of Cardinal Health Elected Chairman of HDA Board of Directors 67
  • 6.33 Sep 22, 2016: ConvaTec Marks 20 Years of AQUACEL Innovation at 5th Conference of the World Union of Wound Healing Societies 68
  • 6.34 Sep 22, 2016: ConvaTec Marks 20 Years of AQUACEL Innovation at 5th Conference of the World Union of Wound Healing Societies 69
  • 6.35 Sep 21, 2016: Smith & Nephew Reinforces Strong Educational Commitment to Advanced Wound Management at World Union of Wound Healing Societies Meeting 70
  • 6.36 Sep 14, 2016: Progenerative Medical Enters into Licensing Agreement with Kinetic Concepts 70
  • 6.37 Sep 08, 2016: Post-operative use of PICO Single use Negative Pressure Wound Therapy improves predictability in wound healing and reduces complications following orthopaedic surgery 71
  • 6.38 Sep 07, 2016: Acelity Launches PREVENA PLUS Incision Management System with Customizable Dressing for a Range of Complex Procedures 72
  • 6.39 Aug 25, 2016: Evidence and expert opinion highlights clinical and aesthetic benefits of PICO Single-use Negative Pressure Wound Therapy in mammoplasty and oncological breast reconstructive surgery 72
  • 6.40 Aug 17, 2016: Innokas was granted almost €700 000 funding by the EU-Comission 73
  • 6.41 Aug 15, 2016: IASIS Healthcare Announces Third Quarter 2016 Results 75
  • 6.42 Aug 04, 2016: ConvaTec Enters $1.7B Negative Pressure Wound Therapy Market with Launch of Avelle System 77
  • 6.43 Aug 02, 2016: Cardinal Health Reports Q4 And Fiscal 2016 Results, Provides Fiscal 2017 Outlook 77
  • 6.44 Jul 28, 2016: Smith & Nephew Second Quarter Trading and First Half 2016 Results 79
  • 6.45 Jul 28, 2016: Invacare Announces Changes to Its Board of Directors 83
  • 6.46 Jul 28, 2016: Invacare Announces Financial Results for the Second Quarter and First Six Months of 2016 83
  • 6.47 Jul 28, 2016: Oculus Innovative Sciences Reports Financial Results for First Quarter of Fiscal Year 2017 86
  • 6.48 Jul 11, 2016: CFO to leave Smith & Nephew in early 2017 87
  • 6.49 Jul 06, 2016: Oculus Innovative Sciences Announces Record Monthly and Quarterly Prescription Data 87
  • 6.50 Jun 30, 2016: Cardinal Health Appoints Pamela O. Kimmet Chief Human Resources Officer 88
  • 6.51 Jun 27, 2016: ConvaTec Provides Business Updates 89
  • 6.52 Jun 16, 2016: Oculus Innovative Sciences Reports Financial Results for Fiscal Year 2016 and Fourth Quarter Ending March 31, 2016 89
  • 6.53 May 16, 2016: Health Choice Arizona and Health Choice Generations Awarded URAC Health Plan Accreditation 91
  • 6.54 May 13, 2016: IASIS Healthcare Announces Second Quarter 2016 Results 91

7 Appendix 93

  • 7.1 Methodology 93
  • 7.2 About GlobalData 96
  • 7.3 Contact Us 96
  • 7.4 Disclaimer 96

List of Tables

1.1 List of Tables

  • Table 1: Negative Pressure Wound Therapy (NPWT) - Pipeline Products by Stage of Development 8
  • Table 2: Negative Pressure Wound Therapy (NPWT) - Pipeline Products by Territory 9
  • Table 3: Negative Pressure Wound Therapy (NPWT) - Pipeline Products by Regulatory Path 10
  • Table 4: Negative Pressure Wound Therapy (NPWT) - Pipeline Products by Estimated Approval Date 11
  • Table 5: Negative Pressure Wound Therapy (NPWT) Companies - Pipeline Products by Stage of Development 12
  • Table 6: Negative Pressure Wound Therapy (NPWT) - Pipeline Products by Stage of Development 13
  • Table 7: Acelity L.P. Inc. Pipeline Products & Ongoing Clinical Trials Overview 14
  • Table 8: Negative Pressure Regenerative Medicine - Chronic Wounds - Product Status 14
  • Table 9: Negative Pressure Regenerative Medicine - Chronic Wounds - Product Description 15
  • Table 10: Negative Pressure Regenerative Medicine - Hard Tissue - Product Status 15
  • Table 11: Negative Pressure Regenerative Medicine - Hard Tissue - Product Description 15
  • Table 12: Adept Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 16
  • Table 13: Wound Pressure Device - Product Status 16
  • Table 14: Wound Pressure Device - Product Description 16
  • Table 15: Applied Tissue Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 17
  • Table 16: Next Generation Negative Pressure Wound Therapy Device - Product Status 17
  • Table 17: Next Generation Negative Pressure Wound Therapy Device - Product Description 17
  • Table 18: Invacare Corporation Pipeline Products & Ongoing Clinical Trials Overview 18
  • Table 19: Negative-Pressure Wound Therapy System - Product Status 18
  • Table 20: Negative-Pressure Wound Therapy System - Product Description 18
  • Table 21: LifeMedix, LLC Pipeline Products & Ongoing Clinical Trials Overview 19
  • Table 22: Negative Pressure Wound Care Device - Product Status 19
  • Table 23: Negative Pressure Wound Care Device - Product Description 19
  • Table 24: Montana State University Pipeline Products & Ongoing Clinical Trials Overview 20
  • Table 25: Tissue Cooling Negative Pressure Wound Therapy System - Product Status 20
  • Table 26: Tissue Cooling Negative Pressure Wound Therapy System - Product Description 20
  • Table 27: Otivio AS Pipeline Products & Ongoing Clinical Trials Overview 21
  • Table 28: FlowOx - Next Version - Product Status 21
  • Table 29: FlowOx - Next Version - Product Description 21
  • Table 30: Shieldheart Medtech AB Pipeline Products & Ongoing Clinical Trials Overview 22
  • Table 31: ShieldHeart Protection Device - Product Status 22
  • Table 32: ShieldHeart Protection Device - Product Description 22
  • Table 33: Smith & Nephew Plc Pipeline Products & Ongoing Clinical Trials Overview 23
  • Table 34: RENASYS 3 - Product Status 23
  • Table 35: RENASYS 3 - Product Description 23
  • Table 36: RENASYS TOUCH Connect - Product Status 24
  • Table 37: RENASYS TOUCH Connect - Product Description 24
  • Table 38: University of Pisa Pipeline Products & Ongoing Clinical Trials Overview 25
  • Table 39: SWAN iCare - Product Status 25
  • Table 40: SWAN iCare - Product Description 25
  • Table 41: Wake Forest Baptist Medical Center Pipeline Products & Ongoing Clinical Trials Overview 26
  • Table 42: Mechanical Tissue Resuscitation Device - Product Status 26
  • Table 43: Mechanical Tissue Resuscitation Device - Product Description 26
  • Table 44: Worldwide Innovative Healthcare, Inc. Pipeline Products & Ongoing Clinical Trials Overview 27
  • Table 45: Wound-Pump - Product Status 27
  • Table 46: Wound-Pump - Product Description 27
  • Table 47: Glossary 95

List of Figures

1.2 List of Figures

  • Figure 1: Negative Pressure Wound Therapy (NPWT) - Pipeline Products by Stage of Development 8
  • Figure 2: Negative Pressure Wound Therapy (NPWT) - Pipeline Products by Territory 9
  • Figure 3: Negative Pressure Wound Therapy (NPWT) - Pipeline Products by Regulatory Path 10
  • Figure 4: Negative Pressure Wound Therapy (NPWT) - Pipeline Products by Estimated Approval Date 11
Back to Top